RYGANVI Trademark

Trademark Overview

On Friday, July 9, 2021, a trademark application was filed for RYGANVI with the United States Patent and Trademark Office. The USPTO has given the RYGANVI trademark a serial number of 90819941. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, March 25, 2025. This trademark is owned by Genentech, Inc.. The RYGANVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in neurological disorders including Alzheimers
ryganvi

General Information

Serial Number90819941
Word MarkRYGANVI
Filing DateFriday, July 9, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, March 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in neurological disorders including Alzheimers

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenentech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGenentech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, July 13, 2021NEW APPLICATION ENTERED
Monday, March 7, 2022ASSIGNED TO EXAMINER
Wednesday, March 9, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 9, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, March 9, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 9, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 7, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 25, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, October 26, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, October 26, 2022SOU EXTENSION 1 FILED
Wednesday, October 26, 2022SOU EXTENSION 1 GRANTED
Friday, October 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 19, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 16, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 16, 2023SOU EXTENSION 2 FILED
Tuesday, May 16, 2023SOU EXTENSION 2 GRANTED
Thursday, May 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 20, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 20, 2023SOU EXTENSION 3 FILED
Monday, November 20, 2023SOU EXTENSION 3 GRANTED
Wednesday, November 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 29, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 29, 2024SOU EXTENSION 4 GRANTED
Wednesday, May 29, 2024SOU EXTENSION 4 FILED
Thursday, May 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2024SOU EXTENSION 5 FILED
Tuesday, December 3, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 25, 2025SOU EXTENSION 5 GRANTED
Tuesday, March 25, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 26, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

ryganvi including alzheimers disorders neurological preparations pharmaceutical